(Q37259634)

19 August 2017

1 reference

title

Promises and challenges for the development of Listeria monocytogenes-based immunotherapies (English)

1 reference

19 August 2017

main subject

Listeria monocytogenes

0 references

1 reference

Dirk G Brockstedt

1

1 reference

19 August 2017

Thomas W Dubensky

series ordinal

2

1 reference

19 August 2017

language of work or name

1 reference

1 September 2008

1 reference

Expert Review of Vaccines

19 August 2017

published in

1 reference

19 August 2017

volume

7

1 reference

19 August 2017

issue

7

1 reference

19 August 2017

page(s)

1069-1084

1 reference

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Cooperation of Toll-like receptor signals in innate immune defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

How Toll-like receptors signal: what we know and what we don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Bacterial gene therapy strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Immune responses to Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Innate and adaptive immune responses to Listeria monocytogenes: a short overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Evolutionary struggles between NK cells and viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Toll-dependent control mechanisms of CD4 T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Type I interferon as a stimulus for cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Links between innate and adaptive immunity via type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Innate recognition of bacteria by a macrophage cytosolic surveillance pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Vesicular stomatitis virus: an exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Type I interferon production enhances susceptibility to Listeria monocytogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Cellular resistance to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Cytosolic entry controls CD8+-T-cell potency during bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Priming of memory but not effector CD8 T cells by a killed bacterial vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Distinct in vivo dendritic cell activation by live versus killed Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Apoptosis of mouse dendritic cells is triggered by listeriolysin, the major virulence determinant of Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

In situ imaging of the endogenous CD8 T cell response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Immune responses to gene therapy vectors: influence on vector function and effector mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Intracellular antibody neutralizes Listeria growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

CD8(+)-T-cell response to secreted and nonsecreted antigens delivered by recombinant Listeria monocytogenes during secondary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Listeria monocytogenes as a vaccine vector: virulence attenuation or existing antivector immunity does not diminish therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Listeria-based cancer vaccines that segregate immunogenicity from toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Health risk assessment of Listeria monocytogenes in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

A review of Listeria monocytogenes and listeriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Listeria monocytogenes infection in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Invasion of mammalian cells by Listeria monocytogenes: functional mimicry to subvert cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

How the bacterial pathogen Listeria monocytogenes mediates the switch from environmental Dr. Jekyll to pathogenic Mr. Hyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Listeria pathogenesis and molecular virulence determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Enhanced synthesis of internalin A in aro mutants of Listeria monocytogenes indicates posttranscriptional control of the inlAB mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Safety and immunogenicity in neonatal mice of a hyperattenuated Listeria vaccine directed against human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Conditional lethality yields a new vaccine strain of Listeria monocytogenes for the induction of cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

A truncated Bacillus subtilis dal gene with a 3' ssrA gene tag regulates the growth and virulence of racemase-deficient Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Bacterial delivery of functional messenger RNA to mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

In vivo bactofection: listeria can function as a DNA-cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Vaccination with irradiated Listeria induces protective T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Killed but metabolically active Salmonella typhimurium: application of a new technology to an old vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Dual roles of plcA in Listeria monocytogenes pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Phosphorylation, ubiquitination and degradation of listeriolysin O in mammalian cells: role of the PEST-like sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Listeriolysin O: a phagosome-specific lysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Intracellular induction of Listeria monocytogenes actA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Immunoediting sculpts tumor epitopes during immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

The protein secretion systems in Listeria: inside out bacterial virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Identification of a second Listeria secA gene associated with protein secretion and the rough phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Immunostimulatory monoclonal antibodies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Mechanisms of immune evasion by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

CTLA-4: new insights into its biological function and use in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

The new B7s: playing a pivotal role in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

A clinical development paradigm for cancer vaccines and related biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Clostridia in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Immunization with recombinant Calmette-Guerin bacillus (BCG)-hepatitis C virus (HCV) elicits HCV-specific cytotoxic T lymphocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Bacteriolytic therapy can generate a potent immune response against experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Combination bacteriolytic therapy for the treatment of experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Yeasts encoding tumour antigens in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Cancer immunotherapy: breaking the barriers to harvest the crop

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL Priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.1069

10.1586/14760584.7.7.1069

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference